ACCESSION: MSBNK-SMB_Measured-HSA015P0101003
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 22
COMMENT: RAW_SPEC {'EL01_pos_1264': {'bp': 561653.0, 'sum': 1800272.0}, 'EL16_pos_1258': {'bp': 535788.0, 'sum': 1782409.0}, 'EL18_pos_1264': {'bp': 529762.0, 'sum': 1678846.0}, 'EL10_pos_1263': {'bp': 528575.0, 'sum': 1526579.0}, 'EL20_pos_1263': {'bp': 525767.0, 'sum': 1615683.0}, 'EL24_pos_1269': {'bp': 507991.0, 'sum': 1612098.0}, 'EL11_pos_1263': {'bp': 496868.0, 'sum': 1545821.0}, 'EL09_pos_1263': {'bp': 482229.0, 'sum': 1570854.0}, 'EL17_pos_1257': {'bp': 481544.0, 'sum': 1696385.0}, 'EL15_pos_1264': {'bp': 461581.0, 'sum': 1572689.0}, 'EL07_pos_1263': {'bp': 460637.0, 'sum': 1470928.0}, 'EL04_pos_1274': {'bp': 455141.0, 'sum': 1525977.0}, 'EL13_pos_1264': {'bp': 451928.0, 'sum': 1508319.0}, 'EL23_pos_1263': {'bp': 437950.0, 'sum': 1617364.0}, 'EL05_pos_1263': {'bp': 433152.0, 'sum': 1653421.0}, 'EL19_pos_1273': {'bp': 404304.0, 'sum': 1564599.0}, 'EL14_pos_1271': {'bp': 402135.0, 'sum': 1420925.0}, 'EL21_pos_1264': {'bp': 391299.0, 'sum': 1463616.0}, 'EL06_pos_1268': {'bp': 375492.0, 'sum': 1470525.0}, 'EL08_pos_1264': {'bp': 371840.0, 'sum': 1443978.0}, 'EL12_pos_1264': {'bp': 366757.0, 'sum': 1364586.0}, 'EL02_pos_1269': {'bp': 329817.0, 'sum': 1426222.0}}
COMMENT: RETENTION_TIME_STDEV 0.005
COMMENT: PRECURSOR_M/Z_RAW 101.107852
COMMENT: PRECURSOR_M/Z_STDEV 0.000034
COMMENT: PRECURSOR_IN_MS1 mz 101.107333; int 73.094; delta(ppm) 0.826422
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.150; C5H12N2; [M+H]+; delta(ppm) 0.149850
COMMENT: PROPOSED_MF MS-FINDER 4.316; C5H12N2; [M+H]+; delta(ppm) 0.140153
COMMENT: PROPOSED_MF SIRIUS6_Sirius 16.491; C5H12N2; [M+H]+; delta(ppm) 0.140153
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C5H12N2; [M+H]+; delta(ppm) 0.140153
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.733; PVOAHINGSUIXLS-UHFFFAOYSA-N; [M+H]+; CN1CCNCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.733; FQUYSHZXSKYCSY-UHFFFAOYSA-N; [M+H]+; C1CNCCNC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.686; BCIIMDOZSUCSEN-UHFFFAOYSA-N; [M+H]+; C1CNCCC1N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.650; LWMPFIOTEAXAGV-UHFFFAOYSA-N; [M+H]+; C1CCN(CC1)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.622; PEUGKEHLRUVPAN-UHFFFAOYSA-N; [M+H]+; C1CC(CNC1)N
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.837; AUKXFNABVHIUAC-MLHKIVSYNA-N; [M+H]+; (S)-pyrrolidin-2-ylmethylamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.784; BCIIMDOZSUCSEN-UHFFFAOYSA-N; [M+H]+; piperidin-4-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.784; LWMPFIOTEAXAGV-UHFFFAOYSA-N; [M+H]+; piperidin-1-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.784; PEUGKEHLRUVPAN-UHFFFAOYSA-N; [M+H]+; piperidin-3-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.729; FQUYSHZXSKYCSY-UHFFFAOYSA-N; [M+H]+; 1,4-diazepane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.670; PVOAHINGSUIXLS-UHFFFAOYSA-N; [M+H]+; 1-methylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; PVOAHINGSUIXLS-UHFFFAOYSA-N; [M+H]+; 1-methylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; FQUYSHZXSKYCSY-UHFFFAOYSA-N; [M+H]+; 1,4-diazepane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.968; AUKXFNABVHIUAC-MLHKIVSYNA-N; [M+H]+; (S)-pyrrolidin-2-ylmethylamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.968; BCIIMDOZSUCSEN-UHFFFAOYSA-N; [M+H]+; piperidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.968; LWMPFIOTEAXAGV-UHFFFAOYSA-N; [M+H]+; piperidin-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.968; PEUGKEHLRUVPAN-UHFFFAOYSA-N; [M+H]+; piperidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.825; PVOAHINGSUIXLS-UHFFFAOYSA-N; [M+H]+; 1-methylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.392; FQUYSHZXSKYCSY-UHFFFAOYSA-N; [M+H]+; 1,4-diazepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.089; LWMPFIOTEAXAGV-UHFFFAOYSA-N; [M+H]+; piperidin-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.050; JOMNTHCQHJPVAZ-UHFFFAOYSA-N; [M+H]+; 2-methylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.557; BCIIMDOZSUCSEN-UHFFFAOYSA-N; [M+H]+; piperidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.283; NXHFZUVHADJHDW-UHFFFAOYSA-N; [M+H]+; cyclopentylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.254; LPXCHPSTROLSJX-UHFFFAOYSA-N; [M+H]+; pentanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.251; QLBGCEBVDMZPPN-UHFFFAOYSA-N; [M+H]+; N-ethylazetidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.250; ONLNTZCAUWRAJD-UHFFFAOYSA-N; [M+H]+; 1-ethylazetidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.250; PWDZFUBSTVFGCD-UHFFFAOYSA-N; [M+H]+; 1,2-diethyldiaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.204; VEXJSFASSDRQRD-UHFFFAOYSA-N; [M+H]+; 2-methylbutanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.123; PEUGKEHLRUVPAN-RXMQYKEDSA-N; [M+H]+; (3R)-piperidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.096; MYJQGGALXPHWLV-UHFFFAOYSA-N; [M+H]+; cyclopentane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.065; JAKNYTQAGPEFJB-UHFFFAOYSA-N; [M+H]+; piperidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.061; NGZYRKGJWYJGRS-RXMQYKEDSA-N; [M+H]+; (3R)-N-methylpyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.061; UNHOPMIDKWXFMF-UHFFFAOYSA-N; [M+H]+; 1-methylpyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.057; WGOWOSXVPSBDEY-UHFFFAOYSA-N; [M+H]+; 3-methylpyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.057; OQCUGPQOZNYIMV-RXMQYKEDSA-N; [M+H]+; [(3R)-pyrrolidin-3-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.054; AUKXFNABVHIUAC-YFKPBYRVSA-N; [M+H]+; [(2S)-pyrrolidin-2-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.050; RIHYLJLIMZMKTQ-UHFFFAOYSA-N; [M+H]+; 2-(azetidin-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.049; QVSTZIIJZBVKNK-UHFFFAOYSA-N; [M+H]+; (1-methylazetidin-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.038; ZQWRZCZEOLZBQF-UHFFFAOYSA-N; [M+H]+; cyclopentane-1,3-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.026; BUMRERJTUCBSQD-UHFFFAOYSA-N; [M+H]+; N'-cyclopropylethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.026; XCJMSKRFAJQWSS-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)cyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.025; ASADPWMASHWPHP-UHFFFAOYSA-N; [M+H]+; 1-(2-aminoethyl)cyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.025; DLMOTEMIMFOLKK-UHFFFAOYSA-N; [M+H]+; 1-cyclopropylethylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.997; IRQWCOFOSMREBQ-UHFFFAOYSA-N; [M+H]+; N,N-dimethylazetidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.974; IDSMDKUVIBSETN-UHFFFAOYSA-N; [M+H]+; N-methyl-N-(propan-2-ylideneamino)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.973; YCNHOXDFQLCQEU-UHFFFAOYSA-N; [M+H]+; N,1-dimethylazetidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.955; SRKFECRKKOZICT-UHFFFAOYSA-N; [M+H]+; 1,3-dimethylazetidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.950; FNHMJTUQUPQWJN-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylpropanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.941; NWMAYMXDONWXTE-UHFFFAOYSA-N; [M+H]+; 3-methylbutanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.888; RUZMJWPHZFXDSD-UHFFFAOYSA-N; [M+H]+; (1-methylazetidin-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.864; SBBAGNHPQWRXMJ-UHFFFAOYSA-N; [M+H]+; 1-methylcyclobutane-1,3-diamine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C5H13N2; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 2.033
MS$FOCUSED_ION: PRECURSOR_M/Z 101.107339
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0udi-9800000000-109bf4529d32e91b2aed
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0180733 20.4780 55.018781 0.9815 3.68 0.0503 22 ?
  55.0545222 126.6109 55.055230 0.3814 33.05 0.3156 22 f{C4H7}/5.37ppm,p-C1H6N2
  56.0497569 118.7997 56.050469 0.4103 33.10 0.3766 22 f{C3H6N1}/5.02ppm,p-C2H7N1
  57.0337262 14.0816 57.034442 0.9643 3.71 -0.2707 20 ?
  57.0701199 23.5625 57.070836 1.0338 8.38 -0.0672 22 f{C4H9}/4.26ppm,p-C1H4N2
  58.0289579 9.8505 58.029678 1.4476 2.37 0.1971 16 ?
  58.0653738 151.4003 58.066094 0.2583 9.43 0.2117 22 f{C3H8N1}/4.27ppm,p-C2H5N1
  59.0493703 25.5663 59.050094 0.8637 6.60 -0.2750 22 ?
  71.0492518 13.8417 71.049995 1.3090 4.42 0.0271 20 ?
  72.0444989 24.3324 72.045242 1.0549 3.79 0.1937 22 ?
  72.0808948 71.2021 72.081638 0.7353 7.94 0.3789 22 f{C4H10N1}/1.65ppm,p-C1H3N1
  73.0761478 343.5860 73.076890 0.3421 59.72 0.7888 22 f{C3H9N2}/1.68ppm,p-C2H4
  74.0237618 42.2546 74.024503 0.7970 14.42 0.4026 22 ?
  74.0601146 40.8753 74.060856 0.7156 11.54 0.2716 22 ?
  74.0794487 9.9219 74.080190 1.0664 3.13 0.1474 20 ?
  74.0965346 267.4996 74.097276 0.3104 11.88 -0.0356 22 f{C4H12N1}/1.47ppm,p-C1H1N1
  81.0699360 11.4668 81.070662 1.1595 3.38 0.1691 17 ?
  81.9450379 25.2429 81.945761 0.9030 4.03 -0.0017 22 ?
  82.9419411 22.0892 82.942661 0.8801 3.34 0.2247 21 ?
  83.0128155 20.7703 83.013535 0.9637 5.24 -0.1039 21 ?
  83.0491632 22.9540 83.049883 1.0355 7.34 -0.1383 22 ?
  83.0856051 42.7856 83.086325 1.0832 9.70 0.0152 22 ?
  84.0444220 17.2705 84.045138 1.1423 5.82 0.2181 17 ?
  84.9597737 49.1852 84.960486 0.8357 11.02 0.2806 22 ?
  85.0284295 25.7021 85.029141 0.9291 4.58 -0.2740 21 ?
  86.0838876 15.0442 86.084594 1.1849 3.58 0.1117 21 f{C4H10N2}/0.44ppm,p-C1H3
  98.9841981 176.0006 98.984820 0.3637 62.78 -0.2400 22 ?
  99.0441067 9.3598 99.044728 1.3226 2.39 0.2010 17 ?
  100.0392813 16.5204 100.039894 0.9596 4.75 0.2135 20 ?
  100.0757208 71.6404 100.076333 0.4696 12.92 0.4496 22 ?
  100.1120648 10.9432 100.112676 1.1587 3.89 0.0877 19 ?
  100.9884914 16.4391 100.989095 1.2279 6.36 -0.0243 22 ?
  101.0597165 18.2630 101.060320 1.0192 5.68 0.2675 21 ?
  101.1073510 255.9192 101.107954 0.3956 43.03 1.0000 22 f{C5H13N2}/0.26ppm,p
  102.0549636 37.1106 102.055557 0.9407 11.34 0.3845 22 ?
  102.0913880 57.4802 102.091981 1.0383 12.64 -0.0807 22 ?
  102.1277634 999.0000 102.128356 0.2840 0.00 0.1462 22 ?
  103.0866048 75.6202 103.087189 0.5432 13.48 0.6251 22 ?
  103.1310561 15.0368 103.131640 1.0278 2.60 0.2434 22 ?
  117.9661309 15.9413 117.966589 0.9918 5.30 -0.1600 18 ?
  118.9629500 12.2881 118.963399 1.1264 4.26 0.3545 21 ?
PK$NUM_PEAK: 41
PK$PEAK: m/z int. rel.int.
  55.018073 20.48 20
  55.054522 126.61 126
  56.049757 118.80 118
  57.033726 14.08 14
  57.070120 23.56 23
  58.028958 9.85 9
  58.065374 151.40 151
  59.049370 25.57 25
  71.049252 13.84 13
  72.044499 24.33 24
  72.080895 71.20 71
  73.076148 343.59 343
  74.023762 42.25 42
  74.060115 40.88 40
  74.079449 9.92 9
  74.096535 267.50 267
  81.069936 11.47 11
  81.945038 25.24 25
  82.941941 22.09 22
  83.012816 20.77 20
  83.049163 22.95 22
  83.085605 42.79 42
  84.044422 17.27 17
  84.959774 49.19 49
  85.028430 25.70 25
  86.083888 15.04 15
  98.984198 176.00 176
  99.044107 9.36 9
  100.039281 16.52 16
  100.075721 71.64 71
  100.112065 10.94 10
  100.988491 16.44 16
  101.059717 18.26 18
  101.107351 255.92 255
  102.054964 37.11 37
  102.091388 57.48 57
  102.127763 999.00 999
  103.086605 75.62 75
  103.131056 15.04 15
  117.966131 15.94 15
  118.962950 12.29 12
//
